Journals / Nöropsikiyatri Arşivi / 2010 / Cilt: 47 - Sayı: 3

Aripiprazole and neuroleptic malignant syndrome in an adolescent patient: A case report

Ergen hastada aripiprazole bağlı nöroleptik malign sendrom: Bir olgu sunumu

Pages
260–262
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aripiprazole is a new antipsychotic approved for the treatment of schizophrenia, In this report we discussed a case of a mentally retarded and autistic adolescent whom developed NMS after low dose aripiprazole.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuroleptic malignant syndrome (NMS) is a rare disorder seen most often in patients exposed to antipsychotic medications.
📊
Key Findings & Data:This syndrome is generally manifested by hyperthermia, muscle rigidity, autonomic instability, altered mental status, tremors, elevated serum creatinine phosphokinase and leucocytosis.
💡
Conclusion & Impact:Aripiprazole is a new antipsychotic approved for the treatment of schizophrenia, In this report we discussed a case of a mentally retarded and autistic adolescent whom developed NMS after low dose aripiprazole.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neuroleptic malignant syndrome (NMS) is a rare disorder seen most often in patients exposed to antipsychotic medications. This syndrome is generally manifested by hyperthermia, muscle rigidity, autonomic instability, altered mental status, tremors, elevated serum creatinine phosphokinase and leucocytosis. Aripiprazole is a new antipsychotic approved for the treatment of schizophrenia, In this report we discussed a case of a mentally retarded and autistic adolescent whom developed NMS after low dose aripiprazole.

Özet

Nöroleptik Malign Sendrom(NMS) sıklıkla antipsikotik kullanımına bağlı, nadir görülen bir sendromdur. Bu sendromda genellikle hipertermi, kas rigiditesi, otonomik bozukluklar, mental durum değişiklikleri, tremor, serum kreatinfosfokinaz yüksekliği ve lökositoz görülür. Aripiprazol şizofreni tedavisinde kullanılan yeni bir antipsikotiktir. Bu yazıda otizm ve mental retardasyon tanısı ile takip edilen ergen bir hastada düşük doz aripiprazol kullanımı ile ortaya çıkan NMS tablosu tartışılacaktır.

🔖

Cite This Article

KAMIŞLI, Ö., ÖZCAN, Ö., KAPLAN, Y., ÖZCAN, C. (2010). Aripiprazole and neuroleptic malignant syndrome in an adolescent patient: A case report. Nöropsikiyatri Arşivi, Cilt: 47 - Sayı: 3, 260–262. https://ajindex.com/articles/292885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Orhan Ö, Zencirci B, Öksüz H ve ark. Nöroleptik Malign Sendrom: Tedaviye Sertralin Eklenmesi Sonrası Ortaya Çıkan bir Olgunun Sunumu. Klinik Psikofarmakoloji Bülteni 2007; 17:30-3
  2. Doğan N, Kürşad H, Erdem AF, Kızılkaya M. Nöroleptik malign sendromda nadir etyolojik faktörler ve klinik seyir. AÜTD 2003; 35:23-6
  3. Ty EB, Rothner AD. Neuroleptic malignant syndrome in children and adolescents. J Child Neurol. 2001; 16:157-63 4. Hammerman S, Lam C, Caroff SN. Neuroleptic malignant syndrome and aripiprazole. J Am Acad Child Adolesc Psychiatry. 2006 45:639-41
  4. Chakraborty N, Johnston T. Aripiprazole and neuroleptic malignant syndrome. Int Clin Psychopharmacol. 2004; 19:351-3
  5. Brunelle J, Guigueno S, Gouin P et al. Aripiprazole and neuroleptic malignant syndrome. Clin Psychopharmacol. 2007; 27:212-4
  6. Molina D, Tingle LE, Lu X. Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report. Prim Care Companion J Clin Psychiatry. 2007; 9: 148-50
  7. Marshall PB, Mellman TA, Nguyen SX. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. Am J Psychiatry. 2008; 165: 1488-9
  8. Kang SG, Lee HJ, Lee MS, Kim L, Park JS. Atypical neuroleptic malignant syndrome associated with aripiprazole. J Clin Psychopharmacol. 2006; 26: 534
  9. Stahl SM.Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. J Clin Psychiatry. 2001; 62: 923-4
  10. Kastrup A, Schlotter W, Plewnia C, et al. Treatment of tics in tourette syndrome with aripiprazole. J Clin Psychopharmacol. 2005; 25:96-99
  11. Marder SR, McQuade RD, Stock E et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res. 2003; 61:123-36
  12. Croarkin PE, Emslie GJ, Mayes TL. Neuroleptic Malignant Syndrome Associated With Atypical Antipsychotics in Pediatric Patients: A Review of Published Cases. J Clin Psychiatry 2008; 69:1157-65
  13. Neuhut R, Lindenmayer JP, Silva R. Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review.J Child Adolesc Psychopharmacol. 2009; 19:415-22
  14. Palakurthi HB, Parvin MM, Kaplan S. Neuroleptic Malignant Syndrome From Aripiprazole in an Agitated Pediatric Patient. Clınıcal neuropharmacology.22007; 30:47-51
  15. Boyd RD.Neuroleptic malignant syndrome and mental retardation: review and analysis of 29 cases. Am J Ment Retard. 1993; 98: